Expression of VAV1 in the tumour microenvironment of glioblastoma multiforme

Journal of Neuro-Oncology

Volumn 110, Issue 1, 2012, Pages 69-77

  Garcia, Juan Luis ^a   Couceiro, Jose ^b   Gomez Moreta, Juan Antonio ^a   Gonzalez Valero, J M ^a   Briz, Angel Santos ^a   Sauzeau, Vincent ^b   Lumbreras, Eva ^b   Delgado, Manuel ^b   Robledo, Cristina ^b   Almunia, Monica Lara ^a   Bustelo, Xose R ^b   Hernandez, Jesus M ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Expression profile; Glioma; VAV1

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOLECULAR INTERACTION; OVERALL SURVIVAL; PROTO ONCOGENE; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT; UPREGULATION; VAV1 GENE;

ADULT; AGED; BRAIN NEOPLASMS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-VAV; RECEPTOR CROSS-TALK; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 84866393845     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0936-y     Document Type: Article

References (43)

1. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173
2. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H et al (2005) Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65:1678-1686
3. Kitange GJ, Templeton KL, Jenkins RB (2003) Recent advances in the molecular genetics of primary gliomas. Curr Opin Oncol 15:197-203
4. Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H et al (2003) Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 63:6613-6625
5. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T et al (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503-6510
6. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS et al (2003) Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163:1033-1043
7. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M et al (2001) Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61:6885-6891
8. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011-1018
9. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492-507
10. Bustelo XR (2000) Regulatory and signaling properties of the Vav family. Mol Cell Biol 20:1461-1477
11. Sahai E, Marshall CJ (2002) RHO-GTPases and cancer. Nat Rev Cancer 2:133-142
12. Symons M, Settleman J (2000) Rho family GTPases: more than simple switches. Trends Cell Biol 10:415-419
13. Bustelo XR, Sauzeau V, Berenjeno IM (2007) GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. BioEssays 29:356-370
14. Sauzeau V, Sevilla MA, Rivas-Elena JV, de Alava E, Montero MJ et al (2006) Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med 12:841-845
15. Prieto-Sanchez RM, Hernandez JA, Garcia JL, Gutierrez NC, San Miguel J et al (2006) Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q. Br J Haematol 133:642-645
16. Berenjeno IM, Nunez F, Bustelo XR (2007) Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases. Oncogene 26:4295-4305
17. Caloca MJ, Zugaza JL, Bustelo XR (2008) Mechanistic analysis of the amplification and diversification events induced by Vav proteins in B-lymphocytes. J Biol Chem 283:36454-36464
18. Khalil BD, El-Sibai M (2012) Rho GTPases in primary brain tumor malignancy and invasion. J Neurooncol 108(3):333-339
19. Bustelo XR (2001) Vav proteins, adaptors and cell signaling. Oncogene 20:6372-6381
20. Couceiro JR, Martin-Bermudo MD, Bustelo XR (2005) Phylogenetic conservation of the regulatory and functional properties of the Vav oncoprotein family. Exp Cell Res 308:364-380
21. Bustelo XR (2002) Regulation of Vav proteins by intramolecular events. Front Biosci 7:d24-d30
22. Bustelo XR, Suen KL, Leftheris K, Meyers CA, Barbacid M (1994) Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 9:2405-2413
23. Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR et al (2005) Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 7:39-49
24. Lee K, Liu Y, Mo JQ, Zhang J, Dong Z et al (2008) Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. BMC Cancer 8:158
25. Lazer G, Idelchuk Y, Schapira V, Pikarsky E, Katzav S (2009) The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis. J Pathol 219:25-34
26. Salhia B, Tran NL, Chan A, Wolf A, Nakada M et al (2008) The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol 173:1828-1838
27. Nathoo N, Prayson RA, Bondar J, Vargo L, Arrigain S et al (2006) Increased expression of 5-lipoxygenase in high-grade astrocytomas. Neurosurgery 58:347-354
28. Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg JP et al (2000) Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Res 60:1353-1360
29. Holtkamp N, Afanasieva A, Elstner A, van Landeghem FK, Konneker M et al (2005) Brain slice invasion model reveals genes differentially regulated in glioma invasion. Biochem Biophys Res Commun 336:1227-1233
30. Rahaman SO, Sharma P, Harbor PC, Aman MJ, Vogelbaum MA et al (2002) IL-13R{alpha}2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res 62:1103-1109
31. Stettner MR, Wang W, Nabors LB, Bharara S, Flynn DC et al (2005) Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. Cancer Res 65:5535-5543
32. Dransart E, Morin A, Cherfils J, Olofsson B (2005) RhoGDI-3, a promising system to investigate the regulatory function of rhoGDIs: uncoupling of inhibitory and shuttling functions of rhoGDIs. Biochem Soc Trans 33:623-626
33. Lin Q, Fuji RN, Yang W, Cerione RA (2003) RhoGDI is required for Cdc42-mediated cellular transformation. Curr Biol 13:1469-1479
34. Mischel PS, Shai R, Shi T, Horvath S, Lu KV et al (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22:2361-2373
35. Chiang AC, Massague J (2008) Molecular basis of metastasis. N Engl J Med 359:2814-2823
36. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
37. Borg I, Groenen PM (1997) Modern multidimensional scaling: theory and applications. Springer, New York
38. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
39. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV et al (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032-1037
40. Hernandez JM, Mecucci C, Michaux L, Criel A, Stul M et al (1997) del(7q) in chronic B-cell lymphoid malignancies. Cancer Genet Cytogenet 93:147-151
41. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F (1994) Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145:1301-1308
42. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA et al (1992) Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718-725
43. Hernandez JM, Gonzalez MB, Granada I, Gutierrez N, Chillon C et al (2000) Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo. Haematologica 85:481-485